Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-021022-35Phase 4Completed
Phase 4, open-label, single-arm trial of atracurium, sponsored by CHU Saint-Etienne. Primary endpoint: Primary: total horizontal eye deviation under deep general anaesthesia with neuromuscular blockade. Started Jun 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-021022-35.